Workflow
Earnings estimate revisions
icon
Search documents
Tactile Systems Technology (TCMD) Surpasses Q2 Earnings and Revenue Estimates
ZACKS· 2025-08-04 22:36
Company Performance - Tactile Systems Technology (TCMD) reported quarterly earnings of $0.14 per share, exceeding the Zacks Consensus Estimate of $0.09 per share, but down from $0.20 per share a year ago, representing an earnings surprise of +55.56% [1] - The company posted revenues of $78.91 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 6.93%, compared to year-ago revenues of $73.22 million [2] - Over the last four quarters, the company has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Stock Performance and Outlook - Tactile Systems Technology shares have declined approximately 43.7% since the beginning of the year, while the S&P 500 has gained 6.1% [3] - The current consensus EPS estimate for the coming quarter is $0.18 on revenues of $80.53 million, and for the current fiscal year, it is $0.56 on revenues of $309.96 million [7] - The estimate revisions trend for Tactile Systems Technology was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Instruments industry, to which Tactile Systems Technology belongs, is currently in the bottom 37% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Oneok Inc. (OKE) Matches Q2 Earnings Estimates
ZACKS· 2025-08-04 22:26
Core Viewpoint - Oneok Inc. reported quarterly earnings of $1.34 per share, matching the Zacks Consensus Estimate, and showing a slight increase from $1.33 per share a year ago [1]. Financial Performance - Oneok's revenues for the quarter ended June 2025 were $7.89 billion, which missed the Zacks Consensus Estimate by 7.91%, compared to $4.89 billion in the same quarter last year [2]. - The company has exceeded consensus revenue estimates two times in the last four quarters [2]. Stock Performance - Oneok shares have declined approximately 21.3% since the beginning of the year, while the S&P 500 has gained 6.1% [3]. - The stock currently holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the market in the near future [6]. Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.40, with projected revenues of $8.72 billion, and for the current fiscal year, the EPS estimate is $5.49 on revenues of $34.86 billion [7]. - The trend of earnings estimate revisions for Oneok was mixed prior to the earnings release, which may change following the report [6]. Industry Context - The Oil and Gas - Production Pipeline - MLB industry, to which Oneok belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, indicating potential challenges ahead [8].
Palantir Technologies Inc. (PLTR) Q2 Earnings and Revenues Surpass Estimates
ZACKS· 2025-08-04 22:21
Palantir Technologies Inc. (PLTR) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this company would post earnings of $0.13 per share when it actually produced earnings of $0.13, delivering no surprise.Over the last four quarters, the compa ...
Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates
ZACKS· 2025-08-04 22:15
Company Performance - Vertex Pharmaceuticals reported quarterly earnings of $4.52 per share, exceeding the Zacks Consensus Estimate of $4.24 per share, and a significant improvement from a loss of $12.83 per share a year ago, representing an earnings surprise of +6.60% [1] - The company posted revenues of $2.96 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.59% and showing growth from $2.65 billion in the same quarter last year [2] - Over the last four quarters, Vertex has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Vertex shares have increased approximately 14.8% since the beginning of the year, outperforming the S&P 500's gain of 6.1% [3] - The current consensus EPS estimate for the upcoming quarter is $4.55 on revenues of $3.03 billion, and for the current fiscal year, it is $17.78 on revenues of $11.91 billion [7] Industry Outlook - The Medical - Biomedical and Genetics industry, to which Vertex belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Vertex's stock may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8] Future Expectations - The sustainability of Vertex's stock price movement will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The estimate revisions trend for Vertex was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6]
Allegiant Travel (ALGT) Q2 Earnings Beat Estimates
ZACKS· 2025-08-04 22:11
Company Performance - Allegiant Travel reported quarterly earnings of $1.23 per share, exceeding the Zacks Consensus Estimate of $0.83 per share, but down from $1.77 per share a year ago, representing an earnings surprise of +48.19% [1] - The company posted revenues of $689.38 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.29%, compared to $666.28 million in the same quarter last year [2] - Over the last four quarters, Allegiant Travel has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance and Outlook - Allegiant Travel shares have declined approximately 48.9% since the beginning of the year, while the S&P 500 has gained 6.1% [3] - The current consensus EPS estimate for the upcoming quarter is -$1.62 on revenues of $599.03 million, and for the current fiscal year, it is $2.70 on revenues of $2.67 billion [7] - The estimate revisions trend for Allegiant Travel was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Transportation - Airline industry, to which Allegiant Travel belongs, is currently in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Dorman Products (DORM) Q2 Earnings and Revenues Beat Estimates
ZACKS· 2025-08-04 22:11
Core Insights - Dorman Products reported quarterly earnings of $2.06 per share, exceeding the Zacks Consensus Estimate of $1.76 per share, and showing an increase from $1.67 per share a year ago, resulting in an earnings surprise of +17.05% [1] - The company achieved revenues of $540.96 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.53% and up from $502.95 million year-over-year [2] - Dorman Products has consistently outperformed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Outlook - The future performance of Dorman Products' stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's immediate price movement based on recent earnings and future expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.96 on revenues of $522.91 million, and for the current fiscal year, it is $7.82 on revenues of $2.1 billion [7] Industry Context - The Automotive - Replacement Parts industry, to which Dorman Products belongs, is currently ranked in the bottom 22% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - The correlation between near-term stock movements and earnings estimate revisions suggests that investors should monitor these revisions closely to gauge future performance [5][6]
Earnings Estimates Rising for Alnylam (ALNY): Will It Gain?
ZACKS· 2025-08-04 17:21
Core Insights - Alnylam Pharmaceuticals (ALNY) is experiencing solid improvement in earnings estimates, which may lead to continued short-term price momentum [1][2] - The rising trend in estimate revisions reflects growing analyst optimism regarding the company's earnings prospects, which is expected to positively impact its stock price [2][3] Current-Quarter Estimate Revisions - The company is projected to earn $0.50 per share for the current quarter, indicating a year-over-year increase of +200.0% [6] - The Zacks Consensus Estimate for Alnylam has risen by 62.96% over the last 30 days, with four estimates increasing and no negative revisions [6] Current-Year Estimate Revisions - For the full year, Alnylam is expected to earn $1.61 per share, representing a year-over-year change of +8,150.0% [7] - The trend for current-year estimate revisions is positive, with six estimates moving higher and no negative revisions [7] Zacks Rank - Alnylam currently holds a Zacks Rank 2 (Buy), indicating promising estimate revisions that can guide investment decisions [8] - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have historically outperformed the S&P 500 [8] Bottom Line - Investors have shown confidence in Alnylam due to solid estimate revisions, reflected in a 21.1% stock gain over the past four weeks, suggesting potential for further growth [9]
Here's Why BankUnited (BKU) Could be Great Choice for a Bottom Fisher
ZACKS· 2025-08-04 14:56
Core Viewpoint - BankUnited, Inc. (BKU) has experienced a 7.1% decline in shares over the past week, but the formation of a hammer chart pattern suggests potential support and a possible trend reversal in the future [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottoming out, with reduced selling pressure, which could lead to a bullish trend for the stock [2][5]. - A hammer pattern forms when there is a small candle body with a long lower wick, signaling that buyers may be gaining control after a downtrend [4][5]. - The effectiveness of the hammer pattern is enhanced when used alongside other bullish indicators, as its strength is dependent on its placement on the chart [6]. Fundamental Analysis - There has been a recent upward trend in earnings estimate revisions for BKU, which is a positive sign for potential price appreciation [7]. - Over the last 30 days, the consensus EPS estimate for the current year has increased by 2.1%, indicating that analysts expect better earnings than previously predicted [8]. - BKU holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10].
Wex (WEX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
ZACKS· 2025-08-04 14:56
Core Viewpoint - Wex (WEX) shares have recently experienced a decline of 5.3% over the past week, but the formation of a hammer chart pattern suggests potential support and a possible trend reversal in the future [1][2]. Technical Analysis - The hammer chart pattern indicates a potential bottoming out, with selling pressure likely subsiding, which supports a bullish outlook for the stock [2][5]. - A hammer pattern typically forms during a downtrend, where the stock opens lower, makes a new low, but then closes near or above the opening price, indicating buying interest [4][5]. - The effectiveness of the hammer pattern is enhanced when used alongside other bullish indicators, as its strength is dependent on its placement on the chart [6]. Fundamental Analysis - Recent upward revisions in earnings estimates for WEX are a positive fundamental indicator, as trends in earnings estimate revisions correlate strongly with near-term stock price movements [7]. - Over the last 30 days, the consensus EPS estimate for WEX has increased by 3.4%, indicating that analysts expect better earnings than previously predicted [8]. - WEX holds a Zacks Rank of 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks, which typically outperform the market [9][10].
Garmin (GRMN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
ZACKS· 2025-08-04 14:56
Core Viewpoint - Garmin (GRMN) has shown a downtrend recently, losing 7.2% over the past week, but a hammer chart pattern suggests a potential trend reversal as buying interest may be emerging to counteract selling pressure [1][2]. Technical Analysis - The hammer chart pattern indicates a possible bottoming out, with reduced selling pressure, suggesting that bulls may be regaining control [2][5]. - A hammer pattern forms when there is a small difference between opening and closing prices, with a long lower wick, indicating that the stock made a new low but closed near its opening price [4][5]. - This pattern is significant when it occurs at the bottom of a downtrend, signaling a potential trend reversal as bears may have lost control [5][6]. Fundamental Analysis - There is a strong consensus among Wall Street analysts to raise earnings estimates for Garmin, which supports the bullish case for the stock [2][7]. - The consensus EPS estimate for the current year has increased by 2.4% over the last 30 days, indicating analysts' agreement on the company's potential for better earnings [8]. - Garmin currently holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9][10].